Self-limitation of intravenous tocolysis with beta2-adrenergic agonists is mediated through receptor G protein uncoupling.

Tocolysis with a beta-adrenergic receptor agonist is the most common approach to premature labor management after the 25th wk of pregnancy. However, prolonged treatment is associated with a marked loss of efficacy. The biochemical mechanisms involved remain unclear. This study was undertaken to investigate the effect of fenoterol on beta-adrenergic receptor signal transduction in human myometrium. Myometrial biopsy specimens were obtained from 40 women at cesarean section between the 25th and 34th wk of pregnancy. Nineteen patients had received no tocolysis (controls, group I) and 21 had been treated with fenoterol (<48 h in 10, group II; > or = 48 h in 11, group III). As methods we used membrane preparation, adenylyl cyclase assay and cAMP RIA. Adenylyl cyclase activity was determined by the measurement of cAMP levels to evaluate signal transduction after stimulation of beta-adrenergic receptors with isoproterenol, G protein with GTP, and adenylyl cyclase with forskolin. The functional activity of GTP-binding regulatory proteins (G(s)) and adenylyl cyclase was not altered by fenoterol treatment. In the control group, the increase in adenylyl cyclase activity in response to GTP plus isoproterenol was greater than in response to GTP alone. The increase was reduced by 50% in group II and was insignificant in group III. There was no correlation between gestational age and basal adenylyl cyclase activity. Intravenous tocolysis with the beta2-adrenergic receptor agonist fenoterol leads to complete desensitization of the beta-adrenergic receptor system. In addition to the known reduction in receptor number (down-regulation) as underlying mechanism, uncoupling of the receptor from the stimulatory G protein G(s) was identified.

[1]  T. Wieland,et al.  Apparent up‐regulation of stimulatory G‐protein α subunits in the pregnant human myometrium is mimicked by elevated smoothelin expression 1 , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  A. López Bernal,et al.  Expression of G-protein-coupled receptor kinases in pregnant term and non-pregnant human myometrium. , 1999, The Journal of endocrinology.

[3]  A Ohlsson,et al.  Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. , 1998, The New England journal of medicine.

[4]  P. Rice,et al.  Relaxation of isolated human myometrial muscle by β2 -adrenergic receptors but not β1 -adrenergic receptors , 1998 .

[5]  C. Legrand,et al.  Molecular mechanisms of adenylyl cyclase desensitization in pregnant rat myometrium following in vivo administration of the beta-adrenergic agonist, isoproterenol. , 1998, Biology of reproduction.

[6]  Robert J. Lefkowitz,et al.  Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A , 1997, Nature.

[7]  N. Christensen,et al.  Effect of pregnancy on rat myometrial beta 2-adrenoceptor mRNA and isoproterenol-induced relaxation of isolated uterine strips. , 1997, The Journal of endocrinology.

[8]  M. Lohse,et al.  Tocolytic therapy with fenoterol induces selective down-regulation of beta-adrenergic receptors in human myometrium. , 1997, The Journal of clinical endocrinology and metabolism.

[9]  James Inglese,et al.  Protein kinases that phosphorylate activated G protein‐coupled receptors , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  B. Kobilka,et al.  The peptide product of a 5' leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. , 1994, The Journal of biological chemistry.

[11]  M. Böhm,et al.  Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. , 1994, Circulation research.

[12]  M. Lohse,et al.  Molecular mechanisms of membrane receptor desensitization. , 1993, Biochimica et biophysica acta.

[13]  C. Pauerstein,et al.  Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. , 1993, American journal of obstetrics and gynecology.

[14]  M. Caron,et al.  Turning off the signal: desensitization of β‐adrenergic receptor function , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  M. Michel,et al.  Decreased myometrial β‐adrenoceptors in women receiving β2‐adrenergic tocolytic therapy: Correlation with lymphocyte β‐adrenoceptors , 1989 .

[16]  C. Malbon,et al.  Down-regulation of beta-adrenergic receptors: agonist-induced reduction in receptor mRNA levels. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. J. Moore,et al.  Myometrial desensitization after ritodrine infusion. , 1987, The American journal of physiology.

[18]  C. Legrand,et al.  Rat myometrial adrenergic receptors in late pregnancy. , 1987, Biology of reproduction.

[19]  G. Rydén,et al.  β-Adrenergic receptors in human myometrium during pregnancy: Changes in the number of receptors after β-mimetic treatment☆ , 1985 .

[20]  S. Caritis,et al.  Pharmacodynamics of ritodrine in pregnant women during preterm labor. , 1983, American journal of obstetrics and gynecology.

[21]  D. Tashkin,et al.  Reversal of human lymphocyte β‐adrenoceptor desensitization by glucocorticoids , 1982 .

[22]  L. Mahan,et al.  Stimulation of forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase. , 1982, The Journal of biological chemistry.

[23]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[24]  M. Lohse,et al.  Regulation of β-Adrenergic receptor responsiveness modulation of receptor gene expression , 1999 .

[25]  S. Wray Uterine contraction and physiological mechanisms of modulation. , 1993, The American journal of physiology.

[26]  M. Caron,et al.  Regulation of adrenergic receptor responsiveness through modulation of receptor gene expression. , 1991, Annual review of physiology.

[27]  J. Hadcock Down-regulation of β-adrenergic receptor : agonist-induced reduction in mRNA levels , 1988 .